Specifically, pVAX1-HSP40 achieved 53.8%, 61.8% and 57% reduction in the parasite cyst burden, compared with cyst burden using vaccination with pVAX1, PBS, and healthy control, respectively. This evidence concerns the gene DNAJB1 and cyst.